CIK 0001640266
- Accelerated filer
- Smaller reporting company
Voyager Therapeutics, Inc.
Sign in to watch- Ticker
- VYGR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-259-5340
- Business address
- 75 HAYDEN AVENUE, LEXINGTON, MA, 02421
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Medical Officer acquired 105,000 shares (grant or award)
- 4 Open-market sale Chief Operating Officer sold 1,357 shares at $9.88 ($13,407)
- 4 Open-market sale President and CEO sold 12,115 shares at $9.86 ($119,454)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Operating Officer sold 3,966 shares at $7.45 ($29,547)
- 4 Open-market sale President and CEO sold 13,033 shares at $7.46 ($97,226)
- 4 Open-market sale Chief Financial Officer sold 3,764 shares at $7.46 ($28,079)
- 4 Open-market sale Chief Scientific Officer sold 3,967 shares at an average $7.50 ($29,760)
- 4 Grant or award Chief Legal Officer acquired 31,000 shares (grant or award)
Page 4 of 16 · 312 filings